LEXISCAN(R) (REGADENOSON) .08 mg/mL
LEXISCAN(R) (REGADENOSON) · INJECTION, SOLUTION · HF Acquisition Co LLC, DBA HealthFirst
Lexiscan (regadenoson) is an injectable medication that works by activating adenosine receptors and is used during cardiac stress testing to help evaluate how well your heart is working. It is administered intravenously by a healthcare provider as part of a diagnostic procedure to assess blood flow to the heart muscle.
Key Facts
- Brand Name
- LEXISCAN(R) (REGADENOSON)
- Generic Name
- LEXISCAN(R) (REGADENOSON)
- NDC Code (Product)
51662-1448- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Strength
- .08 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA022161
- Drug Class
- Adenosine Receptor Agonist [EPC]
- Marketing Start
- 12/10/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is LEXISCAN(R) (REGADENOSON) used for?
Lexiscan (regadenoson) is an injectable medication that works by activating adenosine receptors and is used during cardiac stress testing to help evaluate how well your heart is working. It is administered intravenously by a healthcare provider as part of a diagnostic procedure to assess blood flow to the heart muscle.
Is LEXISCAN(R) (REGADENOSON) a controlled substance?
LEXISCAN(R) (REGADENOSON) is not classified as a controlled substance by the DEA.
What is the generic name for LEXISCAN(R) (REGADENOSON)?
The generic name for LEXISCAN(R) (REGADENOSON) is LEXISCAN(R) (REGADENOSON). There are no other listed brand versions of LEXISCAN(R) (REGADENOSON).
What is the NDC code for LEXISCAN(R) (REGADENOSON) .08 mg/mL?
The NDC (National Drug Code) for LEXISCAN(R) (REGADENOSON) .08 mg/mL is 51662-1448, listed by HF Acquisition Co LLC, DBA HealthFirst.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)